Intazam Khan, MD
Neurology · Astoria, NYNPI 1548352594
Payments from drug & device makers
Across 1,003 payments — averaging $47.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Pfizer$7K
- Teva Pharmaceuticals USA, Inc.$2K
- UCB, Inc.$2K
- Livanova USA, Inc.$2K
- Biogen$1K
- plus $12K from 48 others
What the payments were for
- Speaking & faculty fees$25,71054%
- Travel & lodging$9122%
- Food & beverage$19,72942%
- Education$1,0442%
- Gifts$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$19,907
- QULIPTA$8,123
- NURTEC ODT$6,531
- VNS Therapy$1,550
- GOCOVRI$206
- BRIUMVI$125
- Epidiolex$125
- WAINUA$125
How this compares
$47,396 in reported general payments places this provider in the 80th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 22 | $320,011 |
| IngrezzaValbenazine Tosylate | 25 | $201,781 |
| NuedextaDextromethorphan Hbr/Quinidine | 98 | $164,352 |
| GocovriAmantadine Hcl | 51 | $87,398 |
| Austedo XrDeutetrabenazine | 11 | $79,079 |
| AptiomEslicarbazepine Acetate | 49 | $65,076 |
| QuliptaAtogepant | 41 | $46,100 |
| UbrelvyUbrogepant | 39 | $43,372 |
| Nurtec OdtRimegepant Sulfate | 11 | $23,195 |
| Pregabalin | 489 | $17,652 |
| RytaryCarbidopa/Levodopa | 43 | $17,113 |
| Memantine Hcl ErMemantine Hcl | 247 | $14,127 |
| HorizantGabapentin Enacarbil | 26 | $13,919 |
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,216 |
| ZtlidoLidocaine | 11 | $6,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $187 | $320,01122 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $698 | $201,78125 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $119 | $164,35298 claims |
| AbbVieQulipta, Ubrelvy, Namzaric | $21,607 | $95,68991 claims |
| MDD US Operations, LLCGocovri | $378 | $87,39851 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $2,206 | $79,07911 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $322 | $65,07649 claims |
| PfizerNurtec Odt | $7,334 | $23,19511 claims |
| Amneal Pharmaceuticals LLCRytary | $217 | $17,11343 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $118 | $13,91926 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $874 | $6,15311 claims |
| Upsher-smith Laboratories LLCTopiramate | $18 | $48062 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,623 neurology providers in New York.
Other neurology in Astoria
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
- Krupa PandeyAlbany$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.